fbpx
Subscribe
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

Archive

New Ebola virus research boosts pandemic preparedness

Written by | 5 Mar 2025

New research led by scientists at La Jolla Institute for Immunology (LJI) reveals the workings of a human antibody called mAb 3A6, which may prove to be an… read more.

Antibody reduces allergic reactions to multiple foods in NIH trial

Written by | 24 Dec 2023

A monoclonal antibody treatment significantly increased the amounts of multiple common foods that food-allergic children and adolescents could consume without an allergic reaction, according to a planned interim… read more.

Current anti-COVID pills work well against omicron, but antibody drugs are less effective, study finds

Written by | 30 Jan 2022

The drugs behind the new pills to treat COVID-19 remain very effective against the omicron variant of the virus in lab tests, according to a new study. However,… read more.

Unexpected antibody type found in people with malaria infections

Written by | 18 Nov 2021

Malaria, a pathogen transmitted into blood by mosquitoes in tropical climates, is typically thought of as a blood and liver infection. However, in a newly published study, researchers… read more.

Mild COVID-19 induces lasting antibody protection, study finds

Written by | 4 Jun 2021

People who have had mild illness develop antibody-producing cells that can last lifetime Washington University School of Medicine Months after recovering from mild cases of COVID-19, people still… read more.

Stronger antibody response to more severe disease

Written by | 15 Nov 2020

Sex, age, and severity of disease may be useful in identifying COVID-19 survivors who are likely to have high levels of antibodies that can protect against the disease,… read more.

New vaccine could help halt Alzheimer’s progression

Written by | 12 Nov 2020

Our immune system’s capacity to mount a well-regulated defence against foreign substances, including toxins, weakens with age and makes vaccines less effective in people over age 65..

Newsletter Icon

Subscribe for our mailing list

If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.

Subscribe

You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.